Evidence map›Paper›PMID 39382419›Full record

ArticleThe Indian journal of medical research2024

Identifying interventions that improve medication safety & rational use of medicines in India.

Jerin Jose Cherian, Sudipto Roy, Minna Hakkinen-Wu, Sowparnika Treasa Sabu, Nabendu Chatterjee, ICMR-SRUM Collaborative Network, ICMR-SRUM Collaborative Network: Scorers, ICMR-SRUM Collaborative Network: Technical Advisory Group (TAG)

Abstract read
In one paragraph

Article in The Indian journal of medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jerin Jose CherianClinical Studies and Trials Unit, Division of Development Research, Indian Council of Medical Research, New Delhi, India.
Sudipto RoyClinical Studies and Trials Unit, Division of Development Research, Indian Council of Medical Research, New Delhi, India.
Minna Hakkinen-WuIndependent consultant, Nokia, Finland.
Sowparnika Treasa SabuClinical Studies and Trials Unit, Division of Development Research, Indian Council of Medical Research, New Delhi, India.
Nabendu ChatterjeeDivision of Discovery Research, Indian Council of Medical Research, New Delhi, India.
ICMR-SRUM Collaborative NetworkClinical Studies and Trials Unit, Division of Development Research, Indian Council of Medical Research, New Delhi, India.
ICMR-SRUM Collaborative Network: Scorers
ICMR-SRUM Collaborative Network: Technical Advisory Group (TAG)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & objectives Medication-related harm is known to be the cause for about 1/10th of hospitalizations. Some estimates from India show that about 90 per cent of medicines consumed are inessential or irrational and contribute towards high out-of-pocket expenditure on health. In this context, the Indian Council of Medical Research in 2022 constituted a National Task Force (NTF) to explore possible solutions that could improve safe and rational use of medicines (SRUMs). The objective of this study was to identify research ideas in the field of SRUM through a survey of relevant stakeholders, and further to prioritize the research ideas using a pre-identified set of criteria. Methods The responses from the identified stakeholders were assessed using the Child Health and Nutrition Research Initiative method, which is an established research priority-setting methodology. First, the NTF asked for two to six research ideas from relevant Indian and global stakeholders on solutions to improve SRUM. The ideas were checked for duplicates, re-phrased where necessary and classified into various sub-themes. Subsequently, the research ideas were scored by Indian experts with relevant technical expertise using a pre-defined set of five criteria: innovativeness, effectiveness, translational value, answerability and applicability. Each research idea received from a stakeholder was assigned a score under each of the five criteria. The overall research priority score was calculated as a mean of all five criteria-specific scores and converted into a percentage. Results The final output of the prioritization process was a list of research ideas or questions, ranked by their scores. Total 209 unique ideas were received from 190 respondents, which were scored by 27 experts. The top three research topics on medication safety focused on cost-effective strategies for improving antimicrobial stewardship, safe use of poly-pharmacy in geriatric patients and drug take-back policy interventions. Regarding the rational use of medicine, the top three topics included testing mobile application-based antimicrobial stewardship interventions, development of diagnostics for antimicrobial resistance, and behavioural interventions. Interpretation & conclusions Several priority ideas found in this study also align with those of global priority, e.g., safe disposal practices and enhanced pharmacovigilance, rational use of medicines. Patient engagement, which underlines many of the top scoring ideas found in this study, is also inclined with the top research priorities reported by the WHO priority exercise on research into the safe use of medicines. However, to the best of our knowledge, this is the first such work from a low- and middle- income country on medication safety and rational use of medicines. The findings of this research priority-setting exercise can help to guide research for the development of policy-relevant and novel interventions to improve SRUM in India.

Indexed as

Drug-Related Side Effects and Adverse ReactionsHumansIndiaSurveys and QuestionnairesCHNRIICMRLMICmedication safetyrational drug userational usesafe and rational use of medicines

Identifiers

PMID39382419
PMCPMC11463240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.